Dr. Reddy’s Laboratories (DRREDDY) Share Price Falls 2.44% as Large Cap Stock Drifts Lower
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Dr. Reddy’s Laboratories Share Price is Rs 1,219.5, down 2.44% today, with the company valued at a market capitalisation of Rs 1,02,039.66 crore. The move keeps Dr. Reddy’s Laboratories Share Price in focus for investors tracking Dr. Reddy’s Laboratories Share Price Today, especially because the stock opened above the current level and has already moved through a wide intraday range.The latest Univest figures also place the move alongside steady healthcare sector comparison points, which makes Dr. Reddy’s Laboratories Share Price relevant for stock analysis, fundamental analysis and peer benchmarking. As of 30 September 2026 at 9:23:45 AM IST, the market is still open.
Dr. Reddy's Laboratories (DRREDDY) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,219.5 |
| Previous Close | Rs 1,250 |
| Today's Move | -Rs 30.50 (-2.44%) |
| Open | Rs 1,251.65 |
| High | Rs 1,251.85 |
| Low | Rs 1,219.05 |
| Market Capitalisation | Rs 1,02,039.66 crore |
| Market Cap Category | Large Cap |
Dr. Reddy’s Laboratories Share Price Today shows a decline from the previous close of Rs 1,250 to Rs 1,219.5, a fall of Rs 30.5. The stock opened at Rs 1,251.65, touched a high of Rs 1,251.85 and a low of Rs 1,219.05, placing the last traded price near the lower end of the intraday band. That move also leaves Dr. Reddy’s Laboratories Share Price down 2.44% for the latest session, which is the clearest part of today’s price action. With a market capitalisation of Rs 1,02,039.66 crore, the company sits in the Large Cap category. For readers following Dr. Reddy’s Laboratories Share Price Live, the key takeaway is the gap between the opening level and the current level, followed by the narrow distance between the day low and the present trade. That makes Dr. Reddy’s Laboratories Share Price important to watch alongside fundamentals and sector valuation.
Why Dr. Reddy’s Laboratories (DRREDDY) May Be Moving Today
Dr. Reddy's Laboratories (DRREDDY) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,02,039.66 crore |
| P/E Ratio | 32.38x |
| P/B Ratio | 2.73x |
| ROE | 11.69% |
| ROCE | 13.75% |
| EPS | Rs 38.6 |
| Book Value Per Share | Rs 457.39 |
| Dividend Yield | 0.64% |
Dr. Reddy’s Laboratories Share Price sits in the context of a Large Cap pharma business with a market capitalisation of Rs 1,02,039.66 crore and enterprise value that investors usually examine alongside valuation ratios. The stock trades at a P/E ratio of 32.38 and a P/B ratio of 2.73, while ROE stands at 11.69% and ROCE at 13.75%. EPS is Rs 38.6, which helps explain the earnings base behind Dr. Reddy’s Laboratories Share Price. Book value is Rs 457.39 per share, giving another anchor for Dr. Reddy’s Laboratories Share Price analysis. Dividend yield is 0.64%, which reflects the historical payout relative to the current price. In relative terms, these numbers place Dr. Reddy’s Laboratories Share Price close to the broader industry median on earnings multiple and slightly below the industry median on book multiple. For investors studying Dr. Reddy’s Laboratories Share Price Today, the main question is whether the current valuation already captures the earnings quality reflected in ROE and ROCE. Univest data helps frame that comparison without turning it into a forecast.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 32.38x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 2.73x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 11.69% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 13.75% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 1,02,039.66 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Dr. Reddy’s Laboratories Share Price should also be read against the Healthcare sector and the Pharmaceuticals & Drugs industry, where the benchmark covers 199 companies. The company P/E of 32.38 is marginally below the benchmark median of 32.43 and far below the benchmark average of 49.46, which tells you that Dr. Reddy’s Laboratories Share Price is not trading at the higher end of the group on earnings alone. The company P/B of 2.73 is also slightly below the benchmark median of 2.89 and well below the benchmark average of 4.38. ROE at 11.69% is almost identical to the benchmark median of 11.7% and above the benchmark average of 10.68%, while ROCE at 13.75% is above the benchmark median of 13.61% and the average of 13.4%. In market-cap terms, the benchmark median is Rs 776.09 crore, while Dr. Reddy’s Laboratories Share Price belongs to a much larger company at Rs 1,02,039.66 crore. That combination keeps Dr. Reddy’s Laboratories Share Price relevant for healthcare sector analysis and industry comparison.
Within the industry, the move in Dr. Reddy’s Laboratories Share Price sits alongside a valuation band that spans from 3.4 to 699.02 on P/E and from -9.51 to 25.59 on P/B. That wide spread shows how varied pharmaceuticals valuation can be across the benchmark group. On the current figures, Dr. Reddy’s Laboratories Share Price looks closer to the middle of the pack than to the extremes, which is useful for anyone comparing healthcare stock performance, market cap and financial analysis on Univest. Sector performance itself is best read through the benchmark set rather than a single headline number, and Dr. Reddy’s Laboratories Share Price Today remains part of that broader Healthcare context.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
Dr. Reddy’s Laboratories Share Price can be compared with listed peers such as Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla On market cap, Dr. Reddy’s Laboratories Share Price is below Sun Pharmaceutical Industries at Rs 4,41,477.63 crore and Divi’s Laboratories at Rs 2,53,031.38 crore, but above Zydus Lifesciences at Rs 1,20,897.46 crore and Cipla at Rs 1,12,205.15 crore. On P/E, Dr. Reddy’s Laboratories Share Price at 32.38 is below Sun Pharmaceutical Industries at 36.9 and far below Divi’s Laboratories and Torrent Pharmaceuticals, but above Zydus Lifesciences at 26.42 and Cipla at 33.15 by only a small gap. On ROE and ROCE, Dr. Reddy’s Laboratories Share Price sits below the stronger return profiles of Torrent Pharmaceuticals and Lupin in the wider peer set, while staying near the middle against Zydus Lifesciences and Cipla Univest data shows a balanced position rather than an extreme valuation case.
Why Investors Are Watching Dr. Reddy’s Laboratories
- Dr. Reddy’s Laboratories Share Price is down 2.44% and is trading near the lower end of the intraday range.
- Dr. Reddy’s Laboratories Share Price Today is being assessed against a market capitalisation of Rs 1,02,039.66 crore.
- Dr. Reddy’s Laboratories Share Price sits close to the industry median on P/E and slightly below it on P/B.
- ROE and ROCE for Dr. Reddy’s Laboratories Share Price are near the benchmark median, which matters in healthcare comparison work.
- Recent company updates around product plans, margins and strategic acquisitions may keep Dr. Reddy’s Laboratories Share Price in focus.
About Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company develops and markets pharmaceutical products across therapeutic areas, with attention from investors often centred on its product pipeline, international business and operating metrics. Dr. Reddy’s Laboratories Share Price reflects a large established healthcare business with a market cap above Rs 1 lakh crore and a valuation profile that remains visible in peer comparison work. The business profile matters because Dr. Reddy’s Laboratories Share Price Today is not only about the intraday move; it also represents a company with recurring product-led revenue drivers and a broad market presence. For Univest readers, this helps place Dr. Reddy’s Laboratories Share Price within company overview, financial analysis and sector analysis in one view.
Track Dr. Reddy’s Laboratories Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Dr. Reddy’s Laboratories Share Price on Univest for live price updates, valuation ratios, 52-week levels, company financials and market insights. The platform also helps compare Dr. Reddy’s Laboratories Share Price with peers in the Healthcare sector and review Dr. Reddy’s Laboratories Share Price Today alongside broader market context. Univest keeps the focus on clear factual updates rather than noisy commentary.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Dr. Reddy's Laboratories Share Price fall today?
Ans. Dr. Reddy's Laboratories Share Price fell 2.44% to Rs 1,219.5 from the previous close of Rs 1,250.
What is Dr. Reddy's Laboratories Share Price Today?
Ans. Dr. Reddy's Laboratories Share Price Today is Rs 1,219.5. The stock opened at Rs 1,251.65, moved between Rs 1,219.05 and Rs 1,251.85, and remains a Large Cap healthcare stock. The previous close was Rs 1,250.
How much has Dr. Reddy's Laboratories Share Price changed today?
Ans. Dr. Reddy's Laboratories Share Price is down Rs 30.5, or 2.44%, from the previous close. That places the stock close to its intraday low and below the opening level. The previous close was Rs 1,250.
What is the market capitalisation of Dr. Reddy's Laboratories?
Ans. Dr. Reddy's Laboratories Share Price is backed by a market capitalisation of Rs 1,02,039.66 crore. That makes it a Large Cap company in the Healthcare sector and a significant name in Pharmaceuticals & Drugs.
Is Dr. Reddy's Laboratories Share Price expensive versus peers?
Ans. Dr. Reddy's Laboratories Share Price trades at a P/E of 32.38 and a P/B of 2.73. Those numbers sit near the industry median, so the valuation is neither an outlier nor a deep discount within the peer set.
How do ROE and ROCE compare for Dr. Reddy's Laboratories?
Ans. Dr. Reddy's Laboratories Share Price reflects ROE of 11.69% and ROCE of 13.75%. Both are close to or slightly above the benchmark median, which adds context to the stock’s fundamental profile.
What do EPS and book value say about Dr. Reddy's Laboratories Share Price?
Ans. EPS is Rs 38.6 and book value is Rs 457.39 per share. These figures help investors relate Dr. Reddy's Laboratories Share Price to earnings power and accounting net worth on a per-share basis.
Should investors track Dr. Reddy's Laboratories Share Price on Univest?
Ans. Yes, investors tracking Dr. Reddy's Laboratories Share Price can use Univest to review live price, valuation ratios, 52-week levels, peer comparison and company context in one place. That supports a more structured review.
